トラベルワクチンの世界市場 - 成長、将来の見通し、競合分析（2022年～2030年）

世界のトラベルワクチンの市場規模は、2021年の47億3,030万米ドルから2030年までに90億6,890万米ドルに達し、2022年～2030年の予測期間にCAGRで7.5％の安定した成長が予測されています。

当レポートでは、世界のトラベルワクチン市場について調査分析し、市場力学、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 トラベルワクチン市場：競合分析

• 主なトラベルワクチン市場ベンダーの市場ポジショニング
• トラベルワクチン市場ベンダーが採用する戦略
• 主な業界戦略
• 階層分析（2021年 vs. 2030年）

第4章 トラベルワクチン市場：マクロ分析と市場力学

• イントロダクション
• 世界のトラベルワクチンの市場金額（2020年～2030年）
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響の分析
• シーソー分析

第5章 トラベルワクチン市場：タイプ別（2020年～2030年）

• 市場の概要
• 成長と収益の分析：（2021年 vs. 2030年）
• 市場セグメンテーション
  • 定期予防接種
  • 推奨される予防接種
  • 必要な予防接種

第6章 北米のトラベルワクチン市場（2020年～2030年）

• 市場の概要
• トラベルワクチン市場：タイプ別（2020年～2030年）
• トラベルワクチン市場：地域別（2020年～2030年）
  • 北米

第7章 英国・欧州連合のトラベルワクチン市場（2020年～2030年）

• 市場の概要
• トラベルワクチン市場：タイプ別（2020年～2030年）
• トラベルワクチン市場：地域別（2020年～2030年）
  • 英国・欧州連合

第8章 アジア太平洋のトラベルワクチン市場（2020年～2030年）

• 市場の概要
• トラベルワクチン市場：タイプ別（2020年～2030年）
• トラベルワクチン市場：地域別（2020年～2030年）
  • アジア太平洋

第9章 ラテンアメリカのトラベルワクチン市場（2020年～2030年）

• 市場の概要
• トラベルワクチン市場：タイプ別（2020年～2030年）
• トラベルワクチン市場：地域別（2020年～2030年）
  • ラテンアメリカ

第10章 中東・アフリカのトラベルワクチン市場（2020年～2030年）

• 市場の概要
• トラベルワクチン市場：タイプ別（2020年～2030年）
• トラベルワクチン市場：地域別（2020年～2030年）
  • 中東・アフリカ

第11章 企業プロファイル

• Baxter AG
• Bharat Biotech
• GlaxoSmithkline, Plc.
• Inovio Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Novartis AG
• PaxVax Corporation
• Sanofi Pasteur SA
• Valneva SE
• VBI Vaccines, Inc.

List of Tables

• TABLE 1 Global Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 2 Global Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 3 Global Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 4 Global Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 5 North America Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 6 North America Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 7 North America Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 8 North America Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 9 U.S. Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 10 U.S. Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 11 U.S. Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 12 U.S. Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 13 Canada Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 14 Canada Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 15 Canada Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 16 Canada Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 17 Rest of North America Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 18 Rest of North America Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 19 Rest of North America Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 20 Rest of North America Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 21 UK and European Union Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 22 UK and European Union Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 23 UK and European Union Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 24 UK and European Union Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 25 UK Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 26 UK Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 27 UK Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 28 UK Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 29 Germany Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 30 Germany Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 31 Germany Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 32 Germany Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 33 Spain Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 34 Spain Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 35 Spain Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 36 Spain Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 37 Italy Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 38 Italy Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 39 Italy Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 40 Italy Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 41 France Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 42 France Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 43 France Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 44 France Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 45 Rest of Europe Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 46 Rest of Europe Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 47 Rest of Europe Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 48 Rest of Europe Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 49 Asia Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 50 Asia Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 51 Asia Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 52 Asia Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 53 China Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 54 China Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 55 China Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 56 China Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 57 Japan Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 58 Japan Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 59 Japan Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 60 Japan Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 61 India Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 62 India Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 63 India Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 64 India Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 65 Australia Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 66 Australia Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 67 Australia Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 68 Australia Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 69 South Korea Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 70 South Korea Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 71 South Korea Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 72 South Korea Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 73 Latin America Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 74 Latin America Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 75 Latin America Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 76 Latin America Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 77 Brazil Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 78 Brazil Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 79 Brazil Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 80 Brazil Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 81 Mexico Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 82 Mexico Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 83 Mexico Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 84 Mexico Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 85 Rest of Latin America Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 86 Rest of Latin America Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 87 Rest of Latin America Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 88 Rest of Latin America Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 89 Middle East and Africa Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 90 Middle East and Africa Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 91 Middle East and Africa Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 92 Middle East and Africa Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 93 GCC Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 94 GCC Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 95 GCC Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 96 GCC Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 97 Africa Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 98 Africa Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 99 Africa Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 100 Africa Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)
• TABLE 101 Rest of Middle East and Africa Travel Vaccines Market By Type, 2020-2030, USD (Million)
• TABLE 102 Rest of Middle East and Africa Travel Vaccines Market By Routine Vaccination, 2020-2030, USD (Million)
• TABLE 103 Rest of Middle East and Africa Travel Vaccines Market By Recommended Vaccination, 2020-2030, USD (Million)
• TABLE 104 Rest of Middle East and Africa Travel Vaccines Market By Required Vaccination, 2020-2030, USD (Million)

List of Figures

• FIG. 1 Global Travel Vaccines Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Travel Vaccines Market: Quality Assurance
• FIG. 5 Global Travel Vaccines Market, By Type, 2021
• FIG. 6 Global Travel Vaccines Market, By Geography, 2021
• FIG. 7 Market Geographical Opportunity Matrix - Global Travel Vaccines Market, 2021
• FIG. 8 Market Positioning of Key Travel Vaccines Market Players, 2021
• FIG. 9 Global Travel Vaccines Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
• FIG. 10 Global Travel Vaccines Market, By Type, 2021 Vs 2030, %
• FIG. 11 U.S. Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 12 Canada Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 13 Rest of North America Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 14 UK Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 15 Germany Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 16 Spain Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 17 Italy Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 18 France Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 19 Rest of Europe Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 20 China Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 21 Japan Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 22 India Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 23 Australia Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 24 South Korea Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 25 Rest of Asia Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 26 Brazil Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 27 Mexico Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 28 Rest of Latin America Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 29 GCC Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 30 Africa Travel Vaccines Market (US$ Million), 2020 - 2030
• FIG. 31 Rest of Middle East and Africa Travel Vaccines Market (US$ Million), 2020 - 2030

Industry Outlook

The travel vaccines market is set to reach US$ 9,068.9 Mn by 2030 from US$ 4730.3 Mn in 2021 showcasing steady growth at a compounded annual growth rate (CAGR) of 7.5% during the forecast period from 2022 to 2030. As per the research findings of World Tourism Organization (WTO) the number of international arrivals throughout the globe is expected to reach 1.6 billion by 2020. It is estimated that 51% of these travelers accounted for holiday and recreational purpose, 15% tourist traveled for business purpose and 24% reported travel for religious reason and pilgrimage.

Travelers are at a high risk to bacterial and viral infection due to sudden change in humidity, altitude, temperature, poor hygiene and lack of medical services in remote areas etc. The World Health Organization (WHO) has drafted a treatment guideline for the travelers primarily focusing on the importance of vaccination as a preventive measure classified as routine, recommended and required vaccination.

"Required vaccination are gaining prominence due to sudden outbreak of fatal diseases such as ebola, zika and middle east respiratory syndrome"

Routine vaccination holds the largest market share by type in the travel vaccines market. It is helpful in developing immunity in humans against infectious diseases such as influenza, MMR, tuberculosis and diphtheria etc. The other factors responsible for the dominance of routine vaccination are the rising prevalence of infectious diseases and proactive government policies to promote vaccination in all age groups. Favorable reimbursement scenario has a positive impact on the routine vaccination market growth. Recommended vaccination are gaining popularity on account of facts such as increasing number of visitors globally. They are taken two months in advance on physicians recommendation to build immunity against endemic diseases such as cholera, diarrhea, Japanese encephalitis etc. Required vaccination will be the fastest growing segment on account of factors such as sudden outbreak of fatal diseases such as ebola, zika, malaria and middle east respiratory syndrome.

"Increasing public health awareness and well-developed healthcare infrastructure to drive North America market growth"

North America is the clear leader in travel vaccines market. The key parameters which propel the travel vaccines market growth in North America are increasing public health awareness and existence of well-developed healthcare infrastructure. Presence of key players and implementation of treatment guidelines emphasizing preventive care in citizens travelling abroad drive the North America market. European medical agency has made it mandatory for visitors to get vaccinated at the port of entry for infectious diseases such as tuberculosis, swine flu and hepatitis B etc. Asia Pacific will be showcasing fastest growth during the forecast period owing to rising prevalence of infectious diseases and rampant growth in tourism sector. Middle East and Africa performs stringent vaccination of the haj piligrims in order to prevent the spread of middle east respiratory syndrome (MERS). Since the outbreak of fatal diseases such as ebola and zika the healthcare agencies in Latin America and African region the government healthcare bodies have invested huge funds in developing vaccines to protect the health of their citizens.

Market assessment is performed in the scope of report to understand the latest market trends prevailing in the travel vaccines market. Comprehensive study was performed to understand the disease etiology of different infections encountered by travelers throughout the globe and the preventive action taken by the global healthcare agencies. Competitive landscape is covered in the scope of the report to understand the competition existing among key players. The vaccines classified as routine, recommended and required vaccination are covered under the product portfolio segment. Major players providing travel vaccines are Baxter AG, Bharat Biotech, GlaxoSmithkline, Plc., Inovio Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, PaxVax Corporation, Sanofi Pasteur SA, Valneva SE and VBI Vaccines, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Travel Vaccines market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Travel Vaccines market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

Routine Vaccination

Hepatitis B

Influenza

MMR

Tuberculosis

Others

Recommended Vaccination

Cholera

Japanese Encephalitis

Diarrhea

Yellow Fever

Others

Required Vaccination

Malaria

Ebola

Zika

Middle East Respiratory Syndrome

Others

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Travel Vaccines market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Travel Vaccines market?

Which is the largest regional market for Travel Vaccines market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Travel Vaccines market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Travel Vaccines market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Travel Vaccines Market
• 2.2. Global Travel Vaccines Market, By Type, 2021 (US$ Million)
• 2.3. Global Travel Vaccines Market, By Geography, 2021 (US$ Million)
• 2.4. Attractive Investment Proposition by Geography, 2021

3. Travel Vaccines Market: Competitive Analysis

• 3.1. Market Positioning of Key Travel Vaccines Market Vendors
• 3.2. Strategies Adopted by Travel Vaccines Market Vendors
• 3.3. Key Industry Strategies
• 3.4. Tier Analysis 2021 Versus 2030

4. Travel Vaccines Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Travel Vaccines Market Value, 2020 - 2030, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis

5. Travel Vaccines Market: By Type, 2020-2030, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2021 Versus 2030
• 5.3. Market Segmentation
  • 5.3.1. Routine Vaccination
    • 5.3.1.1. Hepatitis B
    • 5.3.1.2. Influenza
    • 5.3.1.3. MMR
    • 5.3.1.4. Tuberculosis
    • 5.3.1.5. Others
  • 5.3.2. Recommended Vaccination
    • 5.3.2.1. Cholera
    • 5.3.2.2. Japanese Encephalitis
    • 5.3.2.3. Diarrhea
    • 5.3.2.4. Yellow Fever
    • 5.3.2.5. Others
  • 5.3.3. Required Vaccination
    • 5.3.3.1. Malaria
    • 5.3.3.2. Ebola
    • 5.3.3.3. Zika
    • 5.3.3.4. Middle East Respiratory Syndrome
    • 5.3.3.5. Others

6. North America Travel Vaccines Market, 2020-2030, USD (Million)

• 6.1. Market Overview
• 6.2. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
• 6.3.Travel Vaccines Market: By Region, 2020-2030, USD (Million)
  • 6.3.1.North America
    • 6.3.1.1. U.S.
      • 6.3.1.1.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 6.3.1.2. Canada
      • 6.3.1.2.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 6.3.1.3. Rest of North America
      • 6.3.1.3.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)

7. UK and European Union Travel Vaccines Market, 2020-2030, USD (Million)

• 7.1. Market Overview
• 7.2. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
• 7.3.Travel Vaccines Market: By Region, 2020-2030, USD (Million)
  • 7.3.1.UK and European Union
    • 7.3.1.1. UK
      • 7.3.1.1.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 7.3.1.2. Germany
      • 7.3.1.2.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 7.3.1.3. Spain
      • 7.3.1.3.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 7.3.1.4. Italy
      • 7.3.1.4.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 7.3.1.5. France
      • 7.3.1.5.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 7.3.1.6. Rest of Europe
      • 7.3.1.6.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)

8. Asia Pacific Travel Vaccines Market, 2020-2030, USD (Million)

• 8.1. Market Overview
• 8.2. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
• 8.3.Travel Vaccines Market: By Region, 2020-2030, USD (Million)
  • 8.3.1.Asia Pacific
    • 8.3.1.1. China
      • 8.3.1.1.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 8.3.1.2. Japan
      • 8.3.1.2.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 8.3.1.3. India
      • 8.3.1.3.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 8.3.1.4. Australia
      • 8.3.1.4.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 8.3.1.5. South Korea
      • 8.3.1.5.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 8.3.1.6. Rest of Asia Pacific
      • 8.3.1.6.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)

9. Latin America Travel Vaccines Market, 2020-2030, USD (Million)

• 9.1. Market Overview
• 9.2. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
• 9.3.Travel Vaccines Market: By Region, 2020-2030, USD (Million)
  • 9.3.1.Latin America
    • 9.3.1.1. Brazil
      • 9.3.1.1.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 9.3.1.2. Mexico
      • 9.3.1.2.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 9.3.1.3. Rest of Latin America
      • 9.3.1.3.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)

10. Middle East and Africa Travel Vaccines Market, 2020-2030, USD (Million)

• 10.1. Market Overview
• 10.2. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
• 10.3.Travel Vaccines Market: By Region, 2020-2030, USD (Million)
  • 10.3.1.Middle East and Africa
    • 10.3.1.1. GCC
      • 10.3.1.1.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 10.3.1.2. Africa
      • 10.3.1.2.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)
    • 10.3.1.3. Rest of Middle East and Africa
      • 10.3.1.3.1. Travel Vaccines Market: By Type, 2020-2030, USD (Million)

11. Company Profile

• 11.1. Baxter AG
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Portfolio
  • 11.1.4. Strategic Initiatives
• 11.2. Bharat Biotech
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Portfolio
  • 11.2.4. Strategic Initiatives
• 11.3. GlaxoSmithkline, Plc.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Portfolio
  • 11.3.4. Strategic Initiatives
• 11.4. Inovio Pharmaceuticals, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Portfolio
  • 11.4.4. Strategic Initiatives
• 11.5. Merck & Co., Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Portfolio
  • 11.5.4. Strategic Initiatives
• 11.6. Novartis AG
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Portfolio
  • 11.6.4. Strategic Initiatives
• 11.7. PaxVax Corporation
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Portfolio
  • 11.7.4. Strategic Initiatives
• 11.8. Sanofi Pasteur SA
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Portfolio
  • 11.8.4. Strategic Initiatives
• 11.9. Valneva SE
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Portfolio
  • 11.9.4. Strategic Initiatives
• 11.10. VBI Vaccines, Inc.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Portfolio
  • 11.10.4. Strategic Initiatives